Header cover image

Chinese Pharmaceuticals & Biotech Your first investment

Results

8

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

8 companies

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.0b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥49.50

7D

-0.6%

1Y

-14.6%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥74.9b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

600436

CN¥123.76

7D

-4.9%

1Y

-42.2%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥40.2b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥23.60

7D

-3.3%

1Y

-23.7%

Beijing Tongrentang

Market Cap: CN¥32.6b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥23.78

7D

-2.7%

1Y

-36.4%

Livzon Pharmaceutical Group

Market Cap: CN¥23.6b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥26.34

7D

-12.3%

1Y

-36.7%

Apeloa PharmaceuticalLtd

Market Cap: CN¥23.3b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥19.71

7D

-11.2%

1Y

18.4%

Tasly Pharmaceutical Group

Market Cap: CN¥22.4b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥14.82

7D

-3.5%

1Y

-13.3%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥15.9b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

600867

CN¥7.95

7D

-6.0%

1Y

-7.7%